More change coming

[anonymous]

No, headcount should remain the same. as the card team goes down to 6-7 per team, as mentioned there will be a slight expansion to the HSBS world; this will offset the card decline

 

[anonymous]

HSBS aQccounts realigned

50+ yrs old. HSBS is the dumbest, most unfulfilling position I have ever had. Currently looking elsewhere. Leadership does nothing more than find things to do and say to justify their own jobs. We are only here because they need us to help justify their manager/director/VP positions. We are just puppets in the shit show.

 

[anonymous]

50+ yrs old. HSBS is the dumbest, most unfulfilling position I have ever had. Currently looking elsewhere. Leadership does nothing more than find things to do and say to justify their own jobs. We are only here because they need us to help justify their manager/director/VP positions. We are just puppets in the shit show.

Yup!!

 

[anonymous]

Totally true. Everything is just a shuffle right now until Germany realizes the truth. Our products are not good. It's a delay game by everyone in the company to try to hide that right now. Trying to hold on to jobs, try to shield/insulate themselves in their jobs but the truth is this: If we had good products NONE of this would be happening.

 

[anonymous]

Totally true. Everything is just a shuffle right now until Germany realizes the truth. Our products are not good. It's a delay game by everyone in the company to try to hide that right now. Trying to hold on to jobs, try to shield/insulate themselves in their jobs but the truth is this: If we had good products NONE of this would be happening.

Our products are just as good if not better than others in their class. Poor marketing/ launch strategy, turnover, constant change, realignments, low morale and shortsighted GPO and hospital packs and contracting did us in. It's been a cluster F*** for a few years. It started with GB and never recovered. My observation.

 

[anonymous]

That is factually not true. Look at the sales and market share of our products and our competitors. They are not as good at all. It's not close. It's not an opinion. If you want to say it's an opinion the ACTUAL sales disagree with you 3 to 1, sometimes more (depending on the product).

 

[anonymous]

50+ yrs old. HSBS is the dumbest, most unfulfilling position I have ever had. Currently looking elsewhere. Leadership does nothing more than find things to do and say to justify their own jobs. We are only here because they need us to help justify their manager/director/VP positions. We are just puppets in the shit show.

 

[anonymous]

[/QUOTE

What I see: culture is broken and needs to be addressed quickly! It has to be more than a pay check. Now it seems trust is so lacking everyone is out for themselves.

Forced rankings. This creates a false sense of security when one is doing well and fear when one is doing poorly. Even GE abandoned this practice. It is also is bad for overall sales at a company. For example I am going to with hold information from you that may grow our business because technically I am competing against you. Also this puts pressure on reps to push the limits and break rules. You have to win but you may get "let go" for numbers at the next layoff.

Lack of communicated vision. What is the plan and how do we create buy in for this plan Do I want to be a part of the organization or do I care?

We do have very good profitable products but they are not moving the way they should. "Net sales". I am not sure this is a strategy that should be for to field sales. It may at a call plan level but when we are trying to guess what plan or should I hide the copay cards. This a a problem. This a a short sided strategy.

We have lots of good talented people here but where is the disconnect? Pradaxa should not be 3 rd in market share. Why are we giving up on spiriva? Way to little voice on the dm portfolio to make it what it need. Too many products without a clear plan on how to move the portfolio. Lilly contract. We have a lot for a little! Two fundamentally different companies

 

[anonymous]

BI sucks as a company. More layoffs coming. Very disorganized management who lack a plan and are focusing solely on justifying their own jobs. Recognize that when things don't go well they will recommend reducing the size of the staff beneath them to the point when their own existence and function comes into question. Now TBM's need to spend a day in the field essentially as a rep calling on clinicians. Why? Apparently because they are "superior" salespeople who will now also be held directly accountable when the sales are not there. They will also be able to "catch" reps who are entering calls on no-see clinics. It is a very sad state of affairs. Trust no one, but lie as much as you can about your superior relationships in those no-see clinics. Just pray to God that the manager doesn't ask to accompany you to see Dr. X on the next ridealong. Oh, and update your resumes...

 

[anonymous]

[/QUOTE
I would like to read this but the message fades away. Can you re-post? Thanks.

 

[anonymous]

BI sucks as a company. More layoffs coming. Very disorganized management who lack a plan and are focusing solely on justifying their own jobs. Recognize that when things don't go well they will recommend reducing the size of the staff beneath them to the point when their own existence and function comes into question. Now TBM's need to spend a day in the field essentially as a rep calling on clinicians. Why? Apparently because they are "superior" salespeople who will now also be held directly accountable when the sales are not there. They will also be able to "catch" reps who are entering calls on no-see clinics. It is a very sad state of affairs. Trust no one, but lie as much as you can about your superior relationships in those no-see clinics. Just pray to God that the manager doesn't ask to accompany you to see Dr. X on the next ridealong. Oh, and update your resumes...

Agreed completely. This is what happens when you have bad products. We can blame this on anything we want but the reality is that we have bad products. Do you think if this was 5 years ago, with our products back then we'd ever be going through this?

 

[anonymous]

Agreed completely. This is what happens when you have bad products. We can blame this on anything we want but the reality is that we have bad products. Do you think if this was 5 years ago, with our products back then we'd ever be going through this?

Yes, and indeed we went through layoff in 09 and then again in 12.

 

[anonymous]

Agreed completely. This is what happens when you have bad products. We can blame this on anything we want but the reality is that we have bad products. Do you think if this was 5 years ago, with our products back then we'd ever be going through this?

I don't think we necessarily have BAD products. Stiolto, Jardiance and Pradaxa are good enough, safe, effective and priced comparable to their competitors. The big issue is that we have a tough time truly competing when we have serious competition. Other than Flomax, what was the last 'commodity' category product that actually LEAD the category? Spiriva doesn't count as that drug has had a free ride for 10+ years.

We simply aren't aggressive enough when we face stiff competition (for example, JnJ, Pfizer, GSK, etc.)

We also don't have solid enough marketing teams to really compete with aggressive messaging. Clinically, we are not inferior to any competitor. Our overall managed care access is strong. Why then is the competition smoking us?

I believe we need to get past this whole CIA mess and take the handcuffs off the sales force and allow them to actually generate some prescription volume. Having the CIA in place hurts efforts to really incentivize the sales force.

We could also use some aggressive management that is NOT afraid to push the envelope (to use an overused cliche.)

Hotter reps would also help.

 

[anonymous]

I don't think we necessarily have BAD products. Stiolto, Jardiance and Pradaxa are good enough, safe, effective and priced comparable to their competitors. The big issue is that we have a tough time truly competing when we have serious competition. Other than Flomax, what was the last 'commodity' category product that actually LEAD the category? Spiriva doesn't count as that drug has had a free ride for 10+ years.

We simply aren't aggressive enough when we face stiff competition (for example, JnJ, Pfizer, GSK, etc.)

We also don't have solid enough marketing teams to really compete with aggressive messaging. Clinically, we are not inferior to any competitor. Our overall managed care access is strong. Why then is the competition smoking us?

I believe we need to get past this whole CIA mess and take the handcuffs off the sales force and allow them to actually generate some prescription volume. Having the CIA in place hurts efforts to really incentivize the sales force.

We could also use some aggressive management that is NOT afraid to push the envelope (to use an overused cliche.)

Hotter reps would also help.

We don't need another CIA dumb-fuck because your sorry ass pushes the envelope. BI doesn't run with short, simple messaging. Instead they want to get reps to go get in the weeds, nitty-gritty type messaging that confuses practitioners.

Ex.,
[BI]P has superior efficacy (but only looks good if you look at relative not actual rates) but more GI bleeds so expect more GI bleeds than warf. Also we can now reverse out all those GI bleeds I've talked to you to death about.
[JnJ.] we are a once a day P with no lawsuits. or thier latest: X does better on diabetes patients. You don't need a reversal agent.
[Pf.] we have less bleed and less death, why would you need a reversal.
Which of these messages works?

Ex.,
[BI] Jar, do you have a negotiating patient who...blah..blah...blah.
[JnJ] Invo pushes out 1 pt A1c drops.
[AZ.] we have a card for F or whatever BS they spout.
Again, what message works?


Shall I give more?

Even go back to Mica, Mira, and even Spva. All we do is show up with: words, words, and more words while the competitors drive home a simple, easy, digestible message. Marketing dept doesn't need to break a CIA to actually craft a message that's short and to the point but BI rarely can get this done.

One last note, I don't know about you but BI has the WORST formulary coverage for its products than any other Pharma I've worked for. It's terrible. Why else is ano growing even though its an ass of a product (yes, pun intended here)? Look up the word "bundling" as it pertains to Pharma.

 

[anonymous]

I don't think we necessarily have BAD products. Stiolto, Jardiance and Pradaxa are good enough, safe, effective and priced comparable to their competitors. The big issue is that we have a tough time truly competing when we have serious competition. Other than Flomax, what was the last 'commodity' category product that actually LEAD the category? Spiriva doesn't count as that drug has had a free ride for 10+ years.

We simply aren't aggressive enough when we face stiff competition (for example, JnJ, Pfizer, GSK, etc.)

We also don't have solid enough marketing teams to really compete with aggressive messaging. Clinically, we are not inferior to any competitor. Our overall managed care access is strong. Why then is the competition smoking us?

I believe we need to get past this whole CIA mess and take the handcuffs off the sales force and allow them to actually generate some prescription volume. Having the CIA in place hurts efforts to really incentivize the sales force.

We could also use some aggressive management that is NOT afraid to push the envelope (to use an overused cliche.)

Hotter reps would also help.

You need to wake up. Stiolto is a shit show.

 

[anonymous]

We don't need another CIA dumb-fuck because your sorry ass pushes the envelope. BI doesn't run with short, simple messaging. Instead they want to get reps to go get in the weeds, nitty-gritty type messaging that confuses practitioners.

Ex.,
[BI]P has superior efficacy (but only looks good if you look at relative not actual rates) but more GI bleeds so expect more GI bleeds than warf. Also we can now reverse out all those GI bleeds I've talked to you to death about.
[JnJ.] we are a once a day P with no lawsuits. or thier latest: X does better on diabetes patients. You don't need a reversal agent.
[Pf.] we have less bleed and less death, why would you need a reversal.
Which of these messages works?

Ex.,
[BI] Jar, do you have a negotiating patient who...blah..blah...blah.
[JnJ] Invo pushes out 1 pt A1c drops.
[AZ.] we have a card for F or whatever BS they spout.
Again, what message works?


Shall I give more?

Even go back to Mica, Mira, and even Spva. All we do is show up with: words, words, and more words while the competitors drive home a simple, easy, digestible message. Marketing dept doesn't need to break a CIA to actually craft a message that's short and to the point but BI rarely can get this done.

One last note, I don't know about you but BI has the WORST formulary coverage for its products than any other Pharma I've worked for. It's terrible. Why else is ano growing even though its an ass of a product (yes, pun intended here)? Look up the word "bundling" as it pertains to Pharma.

Stiolto and the device are a non inferior products, it was the launch of the device that did us in. We certainly did not make it look easy.

 

[anonymous]

And it can't be used in the hospital. Dead in the water.

 

[anonymous]

And it can't be used in the hospital. Dead in the water.

Question: what percent of 100% of respiratory users are started in office versus in a hospital?
Answer: majority are started by practitioners in a office.

You can boo-hoo all you want about the hospital but that's not who make up the bulk of business. Especially when you consider that they went in for an exacerbation so are probably the severe to end stage COPD. That's not the bulk of who you are going for anyway.

The problem is the endless words on the device. If a HCP can't use the device at this point in time then you have failed as a rep.

 

[anonymous]

Stiolto and the device are a non inferior products, it was the launch of the device that did us in. We certainly did not make it look easy.

+1

 

[anonymous]

The device is crap. It gets DEEP into the patients lungs. Umm okay, vs. ellipta? No, we don't have any data. Ultimately what does it translate to in what matters, OUTCOMES/EFFICACY. Well, in our own data, no superiority vs. handihaler. Okay, so let's be clear, it doesn't work any better than HH. Now, Dr.s and patients are BUSY. They don't want to mess with something that takes 10 minutes to learn, assemble and use. Let's be honest here, I can literally show someone how to use Ellipta in less than 5 seconds. Ohhhhh well here's a 7 minute video from BI showing how to use the Respimat? So one takes 5 seconds, and the other 7 minutes. Does one work better than the other? No one know, but we don't think so. Great, give me the one that takes 5 seconds to use.